1. Signaling Pathways
  2. MAPK/ERK Pathway
  3. MAPKAPK2 (MK2)

MAPKAPK2 (MK2)

MAP kinase-activated protein kinase 2 (MAPKAPK2) is an enzyme that in humans is encoded by the MAPKAPK2 gene. MAPKAP kinase-2 (MK2) is originally identified by its phosphorylation of glycogen synthase at serine-7 and the corresponding serine in a peptide (GS peptide-1) modelled after the N-terminus of glycogen synthase.

MAPKAP kinase-2 is a novel protein kinase activated by mitogen-activated protein kinase. This MAP kinase activated protein kinase, termed MAPKAP kinase-2, is distinguished from S6 kinase-II (MAPKAP kinase-1) by its response to inhibitors, lack of phosphorylation of S6 peptides and amino acid sequence.

MAPKAPK2 (MK2) 相关产品 (5):

Cat. No. Product Name Effect Purity
  • HY-12834A
    MK2-IN-1 hydrochloride Inhibitor 99.19%
    MK2-IN-1 hydrochloride 是MAPKAPK2(MK2)激酶高效选择性抑制剂,IC50值0.11uM。
  • HY-112457
    MK-2 Inhibitor III Inhibitor >99.0%
    MK-2 Inhibitor III (compound 16) 是一种具有口服活性的,选择性的,ATP 竞争性的 MAPKAP-K2 (MK-2) 抑制剂,IC50 值为 0.85 nM,MK-2 Inhibitor III 对 MK-3 (IC50=0.21 μM), MK-5 (IC50=0.081 μM), ERK2 (IC50=3.44 μM), MNK1(IC50=5.7 μM) 以及 CDK2, JNK2, IKK2, MSK1, and MSK2 也具有选择性。
  • HY-107427
    PF-3644022 Inhibitor >99.0%
    PF-3644022 是一种有效的,选择性的,口服活性的,具有 ATP 竞争性的 MAPKAPK2 (MK2) 抑制剂,IC50 为 5.2 nM,Ki 为 3 nM。PF-3644022 还抑制 MK3 和 p38 调节/激活激酶 (PRAK),IC50 分别为 53 nM 和 5.0 nM。PF-3644022 有效抑制 TNFα 的产生并具有抗炎作用。
  • HY-108643
    CMPD1 Inhibitor >99.0%
    CMPD1 是一种选择性且非 ATP 竞争性的 p38 MAPK 介导的 MK2 磷酸化抑制剂,表观 Ki (Kiapp) 值为 330 nM。
  • HY-12834
    MK2-IN-1 Inhibitor
    MK2-IN-1是MAPKAPK2(MK2)激酶高效选择性抑制剂,IC50值0.11uM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.